Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development
Ye Jin, Tianjia Liu, Haoming Luo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20

Showing 20 citing articles:

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 35
Kaempferol Targets Global Epigenetic Modifiers to Impedes Growth and Migratory Ability of HeLa Cells
Nazia Afroze, Shafiul Haque, Arif Hussain
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Histone Modification of Colorectal Cancer by Natural Products
Zijun Geng, Meiqi Chen, Qixuan Yu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1095-1095
Open Access | Times Cited: 10
Potential Epigenetic Modifiers Targeting the Alteration of Methylation in Colorectal Cancer
Abdeslam Jaafari
Gene Expression (2024) Vol. 23, Iss. 2, pp. 139-152
Open Access | Times Cited: 3
Ginseng mediates its anticancer activity by inhibiting the expression of DNMTs and reactivating methylation-silenced genes in colorectal cancer
Keisuke Okuno, Muhammad Yogi Pratama, Li Jiang, et al.
Carcinogenesis (2023) Vol. 44, Iss. 5, pp. 394-403
Open Access | Times Cited: 7
Food Chemicals and Epigenetic Targets: An Epi Food Chemical Database
K. Eurídice Juárez‐Mercado, Juan F. Avellaneda-Tamayo, Hassan Villegas-Quintero, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 25322-25331
Open Access | Times Cited: 2
The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
Duong Tien Anh, Nguyen‐Hai Nam, Brigitte Kircher, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1973-1973
Open Access | Times Cited: 6
Role of epigenetic regulatory mechanisms in age‐related bone homeostasis imbalance
Yunyu Zhong, Xueer Zhou, Zijian Pan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 2
Unfolding the complexity of epigenetics in male reproductive aging: a review of therapeutic implications
Ayodeji Folorunsho Ajayi, Mega Obukohwo Oyovwi, Goodness Olusayo Olatinwo, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Epigenome Profiling Identifies H3K27me3 Regulation of Extra-Cellular Matrix Composition in Human Corticogenesis
Nora Ditzer, Ezgi Senoglu, Theresa M. Schütze, et al.
(2024)
Open Access | Times Cited: 2
Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy
Shuang Chen, Ming Huang, Da Xu, et al.
Neurochemistry International (2023) Vol. 173, pp. 105657-105657
Closed Access | Times Cited: 5
Histone deacetylase inhibitors as sanguine epitherapeutics against the deadliest lung cancer
Shabir Ahmad Ganai, Basit Amin Shah, Manzoor Ahmad Yatoo
Advances in cancer research (2023), pp. 163-198
Closed Access | Times Cited: 2
Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness
Chiara Ursino, Cécile Mouric, Laurent Gros, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins
Varvara Maksimova, Valeriia Popova, Anzhelika Bukina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12874-12874
Open Access | Times Cited: 2
Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment
Asad Mohammad, Sudhakar Jha
Cancers (2022) Vol. 15, Iss. 1, pp. 215-215
Open Access | Times Cited: 3
Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review
Mozhdeh Zamani, Farima Safari, Morvarid Siri, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 10
Open Access
Perspectives on materials: Reality and potential of epigenetic drug nano-delivery
Yunxiang Zhang, Derui Xu, Xianglin Hou, et al.
Chemical Engineering Journal (2024), pp. 157746-157746
Closed Access
Food Chemicals in Epigenetic Targets: Towards an Epi Food Chemical Database
K. Eurídice Juárez‐Mercado, Juan F. Avellaneda-Tamayo, Hassan Villegas-Quintero, et al.
(2023)
Open Access | Times Cited: 1
Food Chemicals and Epigenetic Targets: Assembling an Epi Food Chemical Database
K. Eurídice Juárez‐Mercado, Juan F. Avellaneda-Tamayo, Hassan Villegas-Quintero, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top